Clinical trials

  • Durvalumab for Non-small cell lung cancer
  • daratumumab for Multiple myeloma
  • CORAMITUG for Transthyretin amyloid cardiomyopathy (ATTR-CM)
  • PIVMECILLINAM HYDROCHLORIDE for Febrile urinary tract infection (E. coli)
  • Temozolomide for Glioblastoma | Glioblastoma multiforme
  • AZD5335 for Platinum-resistant recurrent ovarian cancer | Platinum-sensitive recurrent ovarian cancer | Lung adenocarcinoma | Endometrial cancer
  • TECLISTAMAB for Relapsed/refractory multiple myeloma
  • PTT-4256 for Solid tumours | Renal cell carcinoma (clear cell) | Papillary renal cell carcinoma | Head and neck squamous cell carcinoma
  • RITLECITINIB TOSILATE for Non-segmental vitiligo
  • TECLISTAMAB for Relapsed/Refractory Multiple Myeloma
  • BNT327 for Triple-negative breast cancer (TNBC)
  • INCA033989 for Myeloproliferative neoplasms | Myelofibrosis | Essential thrombocythemia